Safety of osteoarthritis cell therapy confirmed in new study

A team of researchers from the Center for Stem Cell and Regenerative Medicine (CSCRM) at Tokyo Medical and Dental University (Japan) has recently confirmed the safety of their novel stem cell therapy to treat knee pain caused by osteoarthritis. The treatment, which involves transplanting the patient’s own mesenchymal stem cells (MSCs) into the cartilage of the affected knee, was found to not cause any serious side effects 5 years after transplantation, including tumors. The study was recently published in the journal Stem Cells Translational Medicine. Osteoarthritis, the most common type of arthritis, is caused when the cartilage between bones breaks...